A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives wa1
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new pro1
Researchers from IDIBAPS-Hospital Clínic and CNAG-CRG in Barcelona have led a study to draw the first 3D maps of the genome of healthy and cancerous1
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1
Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
